Natera
A Principal Pharmacovigilance/Device Vigilance professional supports safety surveillance of In Vitro Diagnostic and Software-driven products across their lifecycle, including clinical studies and post-market activities. This role involves collection, assessment, reporting, and management of adverse events, product complaints, and safety data for medicinal products and medical devices, ensuring compliance with global regulatory requirements.
Headquarters
Austin, Texas, United States
Company Size
1001-5000 employees
Founded
2004
Natera is a molecular diagnostics company that develops and commercializes cell-free DNA testing for oncology, women's health, organ health, and rare disease. Its tests are used for cancer detection and monitoring, noninvasive prenatal and carrier screening, transplant rejection assessment, and genomic analysis for rare diseases. Natera's clinically validated tests are processed in CAP/CLIA-certified labs and supported by over 400 peer-reviewed publications.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Natera.
Natera's 1.18% Stock Decline Despite $280M Volume Surge Ranks 429th in Trading Activity
14 hours ago
Principal, Pharmacovigilance / Device Vigilance
Jobgether
Sr Mgr Regulatory Compliance - Medical Events, Vigilance & AE Case Reporting
medlineindustrieslp.com
Complaint Vigilance Specialist I
AbbVie
Medical Device Vigilance Specialist
Insulet
Safety Pharmacovigilance Manager
GSK plc
Local Pharmacovigilance (LPV) Manager – Middle East
Servier